Filing Details
- Accession Number:
- 0001607062-22-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-07 17:22:20
- Reporting Period:
- 2022-01-05
- Accepted Time:
- 2022-01-07 17:22:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1615999 | Neuropathix Inc. | NPTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 944235 | Dean Petkanas | 3805 Old Easton Road Doylestown PA 18902 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-01-05 | 89,000 | $0.05 | 24,770,029 | No | 4 | S | Indirect | See Note |
| Common Stock | Disposition | 2022-01-06 | 120,000 | $0.05 | 24,650,029 | No | 4 | S | Indirect | See Note |
| Common Stock | Disposition | 2022-01-07 | 41,000 | $0.05 | 24,609,029 | No | 4 | S | Indirect | See Note |
| Common Stock | Disposition | 2022-01-07 | 300,000 | $0.00 | 24,309,029 | No | 4 | G | Indirect | See Note |
| Common Stock | Disposition | 2022-01-07 | 250,000 | $0.00 | 24,059,029 | No | 4 | G | Indirect | See Note |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Note |
| No | 4 | S | Indirect | See Note |
| No | 4 | S | Indirect | See Note |
| No | 4 | G | Indirect | See Note |
| No | 4 | G | Indirect | See Note |
Footnotes
- The sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person.
- These shares were sold in multiple transactions at prices falling within those ranges set forth in footnotes (3) and (5) of this Form 4. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the relevant footnotes.
- These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive.
- These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive.
- Aggregate amount of shares beneficially owned by the reporting person includes shares held by him directly as well as indirectly through Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC. The reporting person disclaims beneficial ownership of the securities held by Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC, except to the extent of his pecuniary interest therein.
- Represents a gift of shares by Golden Gate Capital Partners, LLC.
Billionaire Hedge Funds
